Arterial endothelium and atherothrombogenesis: I - Intact endothelium in vascular and blood homeostasis;Endotélio arterial e aterotrombogénese: I - Intervenção do endotélio intacto na homeostasia vascular e sanguĩnea

Revista Portuguesa de Cardiologia

Volumn 25, Issue 11, 2006, Pages 1061-1083

  Silva, J Martins ^a,b   Saldanha, Carlota ^a  

^a UNIVERSITY OF LISBON   (Portugal)

^b INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

Author keywords

Coagulation; Endothelin 1; Endothelium; Fibrinolysis; Nitric oxide; Prostacyclin; Vasomotricity

Indexed keywords

ANGIOTENSIN II; CYCLIC GMP; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROSTACYCLIN; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE; UROTENSIN II;

ARTERY ENDOTHELIUM; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIRCULATION; ENDOTHELIAL DYSFUNCTION; FIBRINOLYSIS; GENETIC PREDISPOSITION; HEART FUNCTION; HEART PROTECTION; HOMEOSTASIS; HUMAN; HYPERTENSION; INTIMA; MEMBRANE FLUIDITY; NONHUMAN; OXIDATIVE STRESS; PROTEIN BINDING; PROTEIN FUNCTION; REVIEW; THROMBOGENESIS; VASOCONSTRICTION; VASODILATATION;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; BLOOD; ENDOTHELIUM, VASCULAR; HOMEOSTASIS; HUMANS; NITRIC OXIDE SYNTHASE; THROMBOSIS; VASOCONSTRICTION; VASODILATION; VASOMOTOR SYSTEM;

EID: 33846388972     PISSN: 08702551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (121)

1. Sacks F.M. - Is there anything to add to our lipid risk factors for coronary heart disease? Am. J. Cardiol. 1995; 75:1263-1264.
2. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Sibershatz H., Kannel W.B. - Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97:1837-1047.
3. Keys S.A. - "Seven Countries: a Multivariate Analysis of Death and Coronary Heart Disease". Cambridge, M.A.: Harvard University Press, 1980.
4. Rosenson R.S., Lowe G.D.O. - Effect of lipid and lipoproteins on thrombosis and rheology. Atherosclerosis 1988; 140:271-280.
5. Bonetti P.O., Lerman L.O., Lerman A. - Endothelial dysfunction: a marker of atherosclerostic risk. Arterioscler. Thromb. Vasc. Biol. 2003; 23:168-175.
6. Maas R., Boger R. - Old and new cardiovascular risk factors: from unresolved issues to new opportunities. Atherosclerosis 2003; 4:5-17.
7. Davignon J., Ganz J. - Role of endothelial dysfunction in atherosclerosis. Circulation. 2004; 109:III27-III32.
8. Lerman A., Burnett J. - Intact and altered endothelium in regulation of vasomotion. Circulation 1992; 86 (Suppl. III): III.12-III.19.
9. Heistad D.D., Marcus M.L., Larsen G. E., Armstrong M.L. - Role of vasa vasorum in nourishment of the aortic wall. Am. J. Physiol. Heart. Circ. Physiol. 1981: 240:H781-H787.
10. Simionescu M., Simionescu N., Palade G.E. - Morphometric data on the endothelium of blood capillaries. J. Cell Biol. 1974; 60:128-1511.
11. Gimbrone M.A.Jr. - Vascular endothelium in health and disease. In: "Molecular Cardiovascular Medicine". E. Haber (ed). New York: Scientific American Inc, 1995; pp. 49-61.
12. Aird W.C. - Endothelium as an organ system. Crit. Care Med. 2004;32:8271-8279.
13. Liepsch D.W. - Effect of blood flow parameters in flow patterns at arterial bifurcations - studies in models. In: "Blood Flow in Large Arteries: Application to Atherosclerosis and Clinical Medicine", D.W. Liepsch (ed), Basel: Karger, 1990, pp. 63-76.
14. Behrendt D., Ganz P. - Endothelial function. From vascular biology to clinical applications. Am. J. Cardiol. 2002; 90:40L-48L.
15. Ku D.D., Caulfield J.B., Kirklin J.K. - Endothelium-dependent responses in human coronary blood vessels. In: "Endothelium Regulation of Vascular Tone", U.S. Ryan, G.M., Rubanyi (eds), New York: Marcel Dekker, Inc, 1992; pp. 197-223.
16. Deng D., Tsalenko A., Vailaya A., Ben-Dor A., Kundu R., Estay I., Tabibiazar R., Kincaid R., Yakhini Z., Bruhn L., Quertermous T - Differences in vascular bed disease susceptibility reflect differences in gene expression response to atherogenio stimuli. Circ. Res. 2006; 98:200-208.
17. Yang Z., Stulz P., Von D.L., Bauer E., Turina M., Lüscher T.F. - Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991; 337:939-943.
18. Georitsen M.E. - Physiologic function of normal endothelial cells. In: "Vascular Medicine: A textbook of vascular biology and diseases". J. Loscalzo, M.A. Creager, V.J. Dzau (eds). Boston: Little, Brown and Company. 1996, pp. 3-38.
19. Mehta D., Malik A.B. - Signaling mechanisms regulating endothelial permeability. Physiol Rev. 2006; 86:279-367.
20. Aird W.A. - Mechanisms of endothelial cell heterogeneity in health and disease. Circ. Res. 2006; 98:159-162.
21. Muller-Delp J.M. - Aging-induced adaptations of microvascular reactivity. Microcirculation 2006; 13:301-314.
22. Brooks A.R., Leekes P.I., Rubanyi G.M. - Gene expression profiling of vascular endothelial cells exposed to fluid mechanical forces: relevance for focal susceptibility to atherosclerosis. Endothelium 2004; 11:45-57.
23. Zeiher A.M., Drexler H., Saurbier B., Just H. - Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J. Clin. Invest. 1993; 92:652-662.
24. Pearson J.A. - The control of production and release of haemostatic factors in the endothelial cell. Baillière's Clin. Haematol. 1993; 6:629-651.
25. Nerem R.M. - Hemodynamics and the vascular endothelium. J. Biomech. Eng. 1993; 115:510-514.
26. Fisher A.B., Chien S., Barakat A.I., Nerem R.M. - Endothehal cellular response to altered shear stress. Am. J. Physiol. Lung .Cell Mol. Physiol. 2001; 281:L529-533.
27. Copley A.L. - Perihemorheology: the bridge between the vessel-blood organ and the organ it penetrates. Biorheology 1989; 26:377-388.
28. Gimbrone M.A. Jr. - Vascular endothelium, hemodynamic forces and atherogenesis. Am. J. Pathol. 1999; 155:1-5.
29. Moncada S., Herman A.G., Higgs E.A., Vane J.R. - Differential formation of prostacyclin (PGX or PGI2) by layers of the arterial wall. Thromb. Res. 1977; 11:323-344.
30. Moncada S., Vane V.R. - Pharmacology and endogeneous roles of prostaglandin endoperoxides, thromboxane A2 and prostacyclin. Pharmacol. Rev. 1979; 30:293-331.
31. Rosemberg R.D., Rosemberg J.S. - Natural anticoagulant mechanisms. J. Clin. Invest. 1984; 74:1-6.
32. Martini J., Cabrales P., Tsai A.G., Intaglietta M. - Mechanotransduction and the homeostatic significance of maintaining blood viscosity in hypotension, hypertension and haemorrhage. J. Intern. Med. 2006; 259:364-372.
33. Kalafatis M., Egan J.O., Mann K.G. - Coagulation factors. In: "The Endothelium in Clinical Practice", G.M. Rubanyi, V.J. Dzau (eds), New York: Marcel Dekker Inc., 1997, pp. 245-264.
34. Hoekstra T., Geleijnse J.M., Scheuten E.G., Kluft C. - Plasminogen activator inhibitor-type 1: its plasma determinants and relation with cardiovascular risk. Thromb. Haemost. 2004; 91:861-872.
35. Janig W. - Organization of the lumbar sympathetic outflow to skeletal muscle and skin of the cat hindlimb. Rev. Physiol. Biochem. Pharmacol. 1985; 102:119-123.
36. Wallin B.G., Fagius J. - Peripheral sympathetic neural activity in conscious humans. Annu. Rev. Physiol. 1988; 50:565-576.
37. Brown M.D. - Metabolic control of blood flow with preference to heart, skeletal muscle and brain. In: "Cardiovascular Regulation", D. Jordan, J. Marchall (eds) London: Portland Press 1975; pp. 113-126.
38. Bolton T.B., Lang R. J., Takewaki T. - Mechanism of action of noradrenaline and carbachol on smooth muscle of guinea-pig anterior mesenteric artery. J. Physiol. 1984; 351:549-572.
39. Hainsworth R., Dinkhill M.J. - Regulation of blood volume. In: "Cardiovascular Regulation", D. Jordan, J. Marchall (eds) London: Portland Press 1975; pp. 77-91.
40. Joyner M.J., Dietz N.M. - Sympathetic vasodilation in human muscle. Acta Physiol Scand. 2003; 177:329-336.
41. Bassenge E - Endothelial regulation of coronary tone. In: "Endothelial Regulation of Vascular Tone", U.S. Ryan, G.M. Rubanyi (eds). New York: Marcel Dekker Inc., 1992, pp. 225-264.
42. Ralevic V., Loncoln J., Burnstock G. - Release of vasoactive substances from endothelial cells. In: "Endothelial Regulation of Vascular Tone", U.S. Ryan, G.M. Rubanyi (eds). New York: Marcel Dekker Inc. 1992, pp. 297-338.
43. Furchgott R.F., Zawadzki J.V. - The obligatory role of endotelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980; 288:373-376.
44. Yanagisawa M., Kurihara H., Kimura S., Tomobe Y., Kobayashi M., Mutsui Y., Yazaki Y., Goto K., Masaki T. - A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332:411-415.
45. Marcondes S., Antunes E. - The plasma and tissue kininogen-kallikrein- kinin system: role in the cardiovascular system. Curr. Med. Chem. Cardiovasc. Hematol. Agents. 2005; 3:33-44.
46. Critz S.D., Coheu M.V., Downey J.M. - Mechanisms of acetylcholine- and bradykinin-induced preconditioning. Vascul. Pharmacol. 2005; 42:201-209.
47. Vanhoutte P.M., Perrault L.P., Vilaine J.P. - Endothelial dysfunction and vascular disease. In: "The Endothelium in Clinical Pratice", G.M. Rubanyi, V.J. Dzau (Eds), New York: Marcel Dekker Inc, 1997, pp. 265-289.
48. Walch L., Brink C., Norel X. - The muscarinic receptor subtypes in human blood vessels. Therapie. 2001; 56:223-226.
49. Palmer R.M., Ferrige A.G., Moncada S. - Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987; 327:524-526.
50. MichelT., Feron O. - Nitric oxide synthases: which, where, how, and why? J. Clin. Invest. 1997; 100:2146-2152.
51. Goligorsky M.S., Li H., Brodsky S., Chen J. - Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am. J. Physiol. Renal. Physiol. 2002; 283:F1-F10.
52. Rapoport K.M., Draznin M.B., Murad F. - Endothelium-dependent relaxation in rat aorta may be mediated through cyclic GMP-dependent protein phosphorylation. Nature 1983; 306:174-176.
53. Kinlay S., Lobby P., Ganz P. - Endothelial function and coronary artery disease. Curr. Opin. Lipidol. 2001; 12:383-389.
54. Simon D.I., Stamler J.S., Jaraki O., Keaney J.F., Osborne J.A., Francis S.A:, Singel D.J., Loscalzo J. - Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler. Thromb. 1993; 13:791-799.
55. Kubes P., Suzuki M., Granger D.N. - Nitric oxide: an endogenous modulator of leukocyte adhesion. Proc. Natl. Acad. Sci. USA. 1991; 88:4651-4655.
56. Yang Y., Loscalzo J. - Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation. 2000; 101:2144-2148.
57. Qian H.S., Neplioueva V., Shetty G.A:, Channon K.M., George S.E. - Nitric oxide synthase gene therapy rapidly reduces adhesion molecule expression and inflammatory cell infiltration in carotid arteries of cholesterol-fed rabbits. Circulation 1999; 99:2979-2982.
58. von der Leyen H.E., Gibbores G.H., Morishita R., Lewis N.P., Zhang L., Nakajima M., Kaneda Y., Cooke J.P., Dzau V.J. - Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA 1995; 92:1137-1141.
59. Muller B., Kleschyov A.L., Alencar J.L., Vanin A., Stoclet J-C. - Nitric oxide transport and storage in the cardiovascular system Ann. N. Y. Acad. Sci. 2002; 962:131-139.
60. Anderson T.J. - Assessment and treatment of endothelial dysfunction in humans. J. Am. Coll. Cardiol. 1999; 34:631-638.
61. Radomski M.W., Palmer R.M., Moncada S. - An L-arginine/nitric oxide pathway present in human platelets regulates aggregation. Proc. Natl. Acad. Sci. (USA) 1990; 87:5193-5197.
62. Harrison D.G. - Cellular and molecular mechanisms of endothelial cell dysfunction. J. Clin. Invest. 1997; 100:2153-2157.
63. Lerman A., Zeiher A.M. - Endothelial function: cardiac events. Circulation 2005; 111:363-368.
64. Grillo M.A., Colombatto S. - Arginine revisited: minireview article. Amino Acids. 2004; 26:345-351.
65. Huynh N.N., Chin-Dusting J. - Amino acids, arginine and nitric oxide in vascular health. Clin. Exp. Pharmacol. Physiol. 2006;33:1-8.
66. Parkinson J.F., Phillips G.B. - Nitric oxide synthases; enzymology and mechanism-based inhibitors. In: "The Endothelium in Clinical Practice", G.M. Rubanyi, V.J. Dzan (eds). New York: Marcel Dekker Inc. 1997; pp. 95-123.
67. Bredt D.S., Snyder S.H. - Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc. Natl. Acad. Sci. USA. 1990; 87:681-685.
68. Wu K.K. - Regulation of endothelial nitric oxide synthase activity and gene expression. Ann. N. Y. Acad. Sci. 2002; 962:122-130.
69. Creager M.A., Gallagher S.J., Girerd X.J., Coleman S.M., Dzan V.J., Cooke J.P. - L-arginine improves endothelium-dependent vasodilation in hypercholesterolemic humans. J. Clin. Invest. 1992; 90:1248-1253.
70. McDonald K.K., Zharikov S., Block E.R., Kilbery M. S. - A caveolar complex between the cationic amino acid transporter 1 and endothelial nitric-oxide synthase may explain the "arginine paradox". J. Biol. Chem. 1997; 272:31213-31216.
71. Rees D.D., Palmer R.M., Schulz R., Hudson H.F., Moncada S. - Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br. J. Pharmacol. 1990; 101:746-752.
72. Achan V., Ho H.K., Heeschen C., Stuehlinger M., Jang J.J., Kimoto M., Vallance P., Cooke J.P. - ADMA regulates angiogenesis: genetic and metabolic evidence. Vasc. Med. 2005; 10:7-14.
73. Joannides R., Haefeli W.E., Linder R., Richard V., Bakkali E.H., Thuillez C., Lüscher T.F. - Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 1995; 91:1314-1319.
74. Lieu D.K., Papone P.A., Barakat A.I. - Differential membrane potential and ion current responses to different types of shear stress in vascular endothelial cells. Am. J. Physiol. Cell. Physiol. 2004; 286:CI367-CI375.
75. Rees D.D., Palmer R.M.J., Moncada S. - Role of endothelium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. (USA) 1989; 86:3375-3378.
76. Vallance P., Collier J., Moncada S. - Effects of endothelium-derived nitric oxide on peripheral arteriolar tone in man. Lancet 1990; 11:997-1000.
77. Moreau P., Takase H., Küng C.F., van Rouijen M-M., Schaffner T., Lüscher T.F. - Structure and function of the rat basilar artery during chronic nitric oxide synthase inhibition. Stroke 1995; 26:1922-1928.
78. Huang Z., Huang P.L., Ma J., Meng W., Ayata C., Fishman M.C., Moskowitz M.A. - Enlarged infarets in endotelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow. Metab. 1996; 16:981-987.
79. Li W., Mital S., Ojaimi C., Csiszar A., Kaley G., Hintze T.H. - Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J. Mol. Cell. Cardiol. 2004; 37:671-680.
80. Kojda G., Laursen J.B., Ramasamy S., Kent J.D., Kurz S., Buchfield J., Shesely E.G., Harrison D.G. - Protein expression, vascular reactivity and soluble guanylate cyclase activity in mice lacking the endothelial cell nitric oxide synthase: contributions of NOS isoforms to blood pressure and heart rate control. Cardiovasc. Res. 1999; 42:206-213.
81. Fagan K.A., Fouty B.W., Tyler R.C., Morris Jr. K.G., Kepler L.K., Sato K., LeCras T.D., Abman S.H., Weinberger H.D., Huang P.L., McMurtry I.F., Radman D.M. - The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J. Clin. Invest. 1999; 103:291-299.
82. Rudic R.D., Shesely E.G., Maeda N., Smithies O., Segal S.S., Sessa W.C. - Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J. Clin. Invest. 1998; 101:731-736.
83. Moroi M., Zhang L., Yasuda T., Virmani R., Gold H.K., Fishman M.C., Huang P.L. - Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular-response to injury in mice. J. Clin. Invest. 1998; 101:1225-1232.
84. Lee T.C., Zhao Y.D., Courtman D.W., Stewart D.J. - Abnormal aortic valve development in mice lacking endothelial nitric oxide synthase. Circulation. 2000; 101:2345-2348.
85. Nordhaug D., Steensrud T., Aghajani E., Korvald C., Myrmel T. - Nitric oxide synthase inhibition impairs myocardial efficiency and ventriculo-arterial matching in acute ischemic heart failure. Eur. J. Heart. Fail. 2004; 6:705-713.
86. Zhang F., White J.C., Iadecola C. - Nitric oxide donors increase blood flow and reduce brain damage in focal ischemia: evidence that nitric oxide is beneficial in the early stages of cerebral ischemia. J. Cereb. Blood Flow Metab. 1994; 14:217-226.
87. Moro M.A., Cardenas A., Hurtado O., Leza J.C., Lizasoain I. - Role of nitric oxide after brain ischaemia. Cell. Calcium. 2004; 36:265-275.
88. Leeson C.P., Hingorani A.D., Mullen M.J. Jeerooburkhan N., Kattenhorn M., Cole T.J., Muller D.P., Lucas A., Humphries S.E. Deanfield J.E. - Glu298Asp endothelial nitric oxide synthase gene polymorphism interacts with environmental and dietary factors to influence endothelial function. Circ. Res. 2002; 90:1153-1158.
89. Radomski M.W., Palmer R.M., Moncada S. - Glucocorticoids inhibit the expression of an inducible, but not the constitutive, nitric oxide synthase in vascular endotelial cells. Proc. Natl. Acad. Sci. (USA), 1990; 87:10043-10047.
90. Eto M., Barandier C., Rathgeb L., Kozai T., Joch H., Wang Z., Luscher T.F. - Thrombin suppresses endothelial nitric oxide synthase and upregulates endothelin-converting enzyme-1 expression by distinct pathways: role of Rho/ROCK and mitogen-activated protein kinase. Circ. Res. 2001; 89:583-90.
91. Rentrop K.P. - Thrombi in acute coronary syndromes: revisited and revised. Circulation. 2000; 101:1619-1626.
92. Petros A., Bennett D., Vallance P. - Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991; 338:1557-1558.
93. Vane J.R., Anggard E.E., Botting R.M. - Regulatory functions of the vascular endothelium. N. Engl. J. Med. 1990; 323:27-36.
94. Ng K.K., Vane J.R. - Conversion of angiotensin I to angiotensin II. Nature 1967; 216:762-766.
95. Berk B.C., Alexander R.W., Brock T.A., Gimbrone M.A. Jr., Webb R.C. - Vasoconstriction: a new activity for platelets derived growth factor. Science 1986; 232:87-90.
96. Yan C., Kim D., Aizawa T., Berk B.C. - Functional interplay between angiotensin II and nitric oxide. Cyclic GMP as a key mediator. Atheroscler. Thromb. Vasc. Biol. 2003; 23:26-36.
97. Turner A.J., Tanzawa K. - Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J. 1997; 11:355-364.
98. Kiowski W., Lüscher T.F., Linder L., Bühler F.R. - Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 1991; 83:469-475.
99. Wagner O.F., Christ G., Wojta J., Vierhapper H., Parzer S., Nowotny P.J., Schneider B., Waldhausl W., Binder B.R. - Polar secretion of endothelin-1 by cultured endothelial cells. J. Biol. Chem. 1992; 267:16066-16068.
100. Verhaar M.C., Strachan F.E., Newby D.E., Cruden N.L., Koomans H.A., Rabelink T.J., Webb D.J. - Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade. Circulation. 1998; 97:752-756.
101. McCabe C., Hicks M.N., Kane K.A., Wainwright C.C. - Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts. Br. J. Pharmacol. 2005; 146:118-128.
102. Schiffrin E.L. - Vascular endothelin in hypertension. Vasc. Pharmacol. 2005; 413:19-29.
103. Goerre S., Wenk M., Bärtsch P., Lüscher T.F., Niroomand S., Hohernhaus H., Oelz O., Reinhart W.H. - Endothelin-1 in pulmonary hypertension associated with high altitude. Circulation 1995; 91:359-364.
104. Minamino T., Kurihara H., Takahashi M., Shimada K., Maemura K., Oda H., Ishikawa T., Uchiyama T., Tanzawa K., Yasaki Y. - Endothelin-converting enzyme expression in the rat vascular injury model and human coronary atherosclerosis. Circulation. 1997; 95:221-230.
105. Quehenberger P., Exner M., Sunder-Plassmann R., Ruzicka K., Bieglmayer C., Endler G., Muellner C., Speiser W., Wagner O. - Leptin induces endothelin-1 in endothelial cells in vitro. Circ. Res. 2002; 90:711-718.
106. Arai H., Hori S., Aramori I., Ohkubo H., Nakanishi S. - Cloning and expression of a cDNA encoding and endothelin receptor. Nature 1990; 348:730-732.
107. Davie N., Haleen S.J., Upton P.D., Polak J.M., Yaxoub M.H., Morrell N.W., Wharton J. - ET(A) and ET(B) receptors modulate the proliferation of human pulmonary artery smooth muscle cells. Am. J. Respir. Crit. Care. Med. 2002; 165:398-405.
108. Lüscher T.F., Yang Z., Tschudi M., Von S.L., Stulz P., Boulanger C., Siebenmann R., Turina M., Bühler F.R. - Interaction between endothelin-1 and endothelium-derived relaxing factor in human arteries and veins. Circ. Res. 1990; 66:1088-1094.
109. Bacon C.R., Davenport A.P. - Endothelin receptors in human coronary artery and aorta. Br. J. Pharmacol. 1996; 117:986-992.
110. Lüscher T.F. - Do we need endothelium antagonists? Cardiovasc. Res. 1993; 27:2089-2093.
111. Best P.J., McKenna C.J., Hasdai D., Holmes D.R.Jr., Lerman A. - Chronic endothelin receptor antagonism preserves coronary endothelial function in experimental hypercholesterolemia. Circulation. 1999; 99:1747-1752.
112. Herrmann J., Best P.J., Ritman E.L., Holmes D.R., Lerman L.O., Lerman A. - Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia. J. Am. Coll. Cardiol. 2002; 39:1555-1561.
113. McKenna C.J., Burke S.E., Opgenorth T.J., Padley R.J., Camrud L.J., Camrud A.R., Johnson J., Carlson P.J., Lerman A., Holmes D.R.Jr., Schwartz R.S. - Selective ET(A) receptor antagonism reduces neointimal hyperplasia in a porcine coronary stent model. Circulation 1998; 97:2551-2556.
114. Battistini B., Chailer P., D'Orleans-Juste P., Briere B., Sirois P. - Growth regulatory properties of endothelins. Peptides. 1993;14: 385-399.
115. Zeiher A.M., Goebel H., Schachinger V., Ihling C. - Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque: a clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995; 91:941-947.
116. Lerman A., Edwards B.S., Hallett J.W., Heublein D.M., Sandberg S.M., Burnett J.J. - Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N. Engl. J. Med. 1991; 325:997-1001.
117. Sutherland A.J., Nataatmadja M.I., Walker P.J., Cuttle L., Garlik R.B., West M.J. - Vascular remodeling in the internal mammary artery graft and association with in situ endothelin-1 and receptor expression. Circulation 2006; 113:1180-1188.
118. Gossl M., Lerman A. - Endothelin: beyond a vasoconstrictor. Circulation. 2006; 113:1156-1158.
119. Ames R.B., e 26 Cols. - Human urotensin-II is a potent vasoconstrictor and agonist for the uphan receptor GRR 14. Nature 1999; 401:282-286.
120. Conlon J.M., Yano K., Waugh D., Hazon N. - Distribution and molecular forms of urotensin II and its role in cardiovascular regulation in vertebrates. J. Exp. Zool. 1996; 275:226-238.
121. Coulouarn Y., Lihrmann I., Jegou S., Anouar Y., Tostivint H., Beauvillain J.C., Conlon J.M., Bern H.A., Vaudry H. - Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc. Natl. Acad. Sci. USA 1998; 95:15803-15808.